Dong-A Q2 sales rise 9.8%

Published: 2012-07-31 06:57:00

Updated: 2012-07-31 06:57:00

Dong-A Pharmaceutical, the country’s top drug maker, said Friday its sales climbed 9.8 percent on-year to 246.5 billion won in the second quarter, fueled by booming demand for over-the-counter (OTC) drugs and overseas sales as well as strategic alliances with GlaxoSmithKline and Bayer.

Operati...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK